Isgro et al. found that the NSE levels of 137 NB patients were all above 100 ng/mL before treatment, all below 100 ng/mL in remission, and all above 100 ng/mL in serum during relapse [34]. The gene discussed is ENO2; the disease is neuroblastoma.